Lv1
20 积分 2025-09-30 加入
Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial
3小时前
待确认
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial
4天前
已完结
Improving outcomes of patients with pancreatic cancer
22天前
已完结
Pancreatic cancer
1个月前
已完结
皖公网安备34019202002308
